Cetirizine Hydrochloride + Ambroxol HydrochlorideThird Party Manufacturing in India

This fixed-dose combination brings together two complementary mechanisms for treating respiratory conditions with allergic and congestion components.

Cetirizine Hydrochloride is a second-generation antihistamine that selectively blocks peripheral histamine H1 receptors. By competitively inhibiting histamine binding, it prevents the allergic cascade responsible for sneezing, rhinorrhea, nasal itching, and watery eyes. Unlike first-generation antihistamines, cetirizine has minimal penetration across the blood-brain barrier, resulting in a significantly lower incidence of sedation.

Ambroxol Hydrochloride is a mucolytic and secretolytic agent that works by several complementary mechanisms. It stimulates the production of pulmonary surfactant in type II alveolar pneumocytes, which acts as an anti-glue factor reducing the adhesion of mucus to the bronchial walls. Ambroxol also increases serous bronchial secretion, making mucus less viscous and more easily transportable. It stimulates ciliary activity in the respiratory tract, enhancing mucociliary clearance. Additionally, ambroxol exhibits anti-inflammatory and antioxidant properties, and has been shown to reduce cytokine release. This combination of effects helps restore the physiological clearance mechanisms of the respiratory tract, facilitating expectoration and reducing cough severity.

This combination is prescribed for the treatment of:

• Allergic Rhinitis with Productive Cough: Used when allergic rhinitis symptoms such as sneezing and nasal congestion are accompanied by thick, viscid mucus that is difficult to expectorate.
• Acute and Chronic Bronchitis: Provides symptom relief in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
• Common Cold with Allergic Component: Addresses both the histamine-mediated symptoms and the congestion caused by thickened secretions.
• Sinusitis and Otitis Media: Helps clear mucus from the sinuses and Eustachian tubes, improving drainage and reducing pressure.

Why Manufacturers Choose This Combination

The cetirizine plus ambroxol combination is widely prescribed in Indian and Asian markets for patients presenting with allergic respiratory symptoms complicated by excessive mucus production. It offers a convenient single-product solution instead of two separate medications, which improves patient compliance. The demand for this syrup formulation is particularly strong in pediatric populations, where liquid dosage forms are preferred. Indian manufacturers have well-established production capabilities for oral suspensions and syrups, with cost-effective supply chains for both active ingredients.

This makes Cetirizine plus Ambroxol a popular product for third party manufacturing in India, especially for PCD franchise networks focusing on respiratory and pediatric therapy segments.